Morgan Stanley analysts have identified Sonic Healthcare (ASX:SHL) as the prime choice in the Australian domestic health services sector.

The company offers an attractive valuation in comparison to other notable Australian healthcare stocks.

Additionally, Sonic Healthcare (ASX:SHL) consistently performs well on earnings drivers and revenues.

Sonic Healthcare’s (ASX:SHL) robust dividend yield and solid balance sheet give it an edge over its competition.

Although the company’s shares have dropped by 0.8% to A$29.510, Sonic Healthcare (ASX:SHL) is down just 1.5% this year, demonstrating resilience when compared to the 1.6% fall of the benchmark S&P/ASX 200 index.

Sonic Healthcare (ASX:SHL) is a healthcare service company based in Australia.